Singapore combatting coronavirus with AI-powered screening system

A new AI-powered temperature screening system is hitting the streets of Singapore to help fight against the ongoing coronavirus (COVID-19) outbreak.

KroniKare, a healthcare technology company based out of Singapore, developed the iThermos solution after precautionary measures were put in place that required citizens to be scanned before entering certain areas. It was designed to be “easily deployed at entrances of places like office buildings and shopping malls” and includes a smartphone camera, thermal camera and laser camera.

The device uses AI technology to screen people much faster than traditional methods, alerting a staff member with a specific sound when someone with a fever is detected. Wait times to enter certain buildings in Singapore are currently 40 minutes or more.

“(For manual screening), it ranges from 20 to 30 seconds to take a reading … that’s the maximum they can do,” said Chua Chee Yong, head of emerging services and capabilities at Singapore’s Integrated Health Information System, in a prepared statement. “For the iThermo, we’re looking at about eight to 10 (screenings) per minute.”

KroniKare noted that 50 of these devices are scheduled to be ready any day now. Another 50 are expected to be available by the end of February.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup